Dose–response correlation for CAR-T cells: a systematic review of clinical studies
The potential of chimeric antigen receptor (CAR) T cells to successfully treat hematological cancers is widely recognized. Multiple CAR-T cell therapies are currently under clinical development, with most in early stage, during which dose selection is a key goal. The objective of this review is to a...
Saved in:
| Main Authors: | Christopher Heery, Matthew J Frigault, Bijal Shah, Anand Rotte, Ayub Ansari, Brad Gliner |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-12-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/10/12/e005678.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A dictionary of human resource management /
by: Heery, Edmund
Published: (2008) -
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Rationale for Clinically Guided Dose Titration to Optimize Individual Response
by: Anjali T. Owens, et al.
Published: (2024-09-01) -
Hospital pharmacist’s roles and responsibilities with CAR-T medicines
by: María Estela Moreno-Martínez, et al.
Published: (2020-01-01) -
A Retrospective Review of Lead Migration Rate in Patients Permanently Implanted with Percutaneous Leads and a 10 kHz SCS Device
by: Mayank Gupta, et al.
Published: (2021-01-01) -
The Clinical Efficacy of Gegen Qinlian Decoction in Treating Type 2 Diabetes is Positively Correlated with the Dose of Coptidis rhizoma: Three Randomized, Doubleblind, Dose-Parallel Controlled Clinical Trials
by: Kang X, et al.
Published: (2024-12-01)